---
title: "V-type Starch–Lycopene Complex Improves Glycemia and Glycogen Stability in db/db Mice via Gut Micr"
id: "pubmed-42907031"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42907031"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42907031/"
doi: "10.1016/j.carbpol.2026.125905"
published_at: "2026-11-15T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# V-type Starch–Lycopene Complex Improves Glycemia and Glycogen Stability in db/db Mice via Gut Micr
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42907031
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42907031/)
- **DOI:** [10.1016/j.carbpol.2026.125905](https://doi.org/10.1016%2Fj.carbpol.2026.125905)
- **Published At:** 2026-11-15T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- Researchers formulated a V-type corn starch-lycopene complex (CS-LYC) combining **resistant starch** with **lycopene** to test metabolic effects in a mouse model of type 2 diabetes. - The complex contained 26.07% resistant starch and 11.8 mg/g lycopene; complexation increased the proportion of the (13Z)-isomer of lycopene and raised lycopene levels in plasma and liver. - In db/db mice, CS-LYC improved insulin sensitivity and glucose homeostasis; the paper attributes these effects to gut microbial remodeling rather than direct hepatic action alone. - The study team observed enrichment of beneficial taxa including **Akkermansia** and Alistipes, plus higher short-chain fatty acids and indole derivative metabolites in treated animals. - CS-LYC preserved intestinal barrier function and stimulated secretion of **GLP-1**, which activated the hepatic **PI3K/AKT** pathway according to the authors' measurements. - Hepatic glycogen architecture shifted toward a higher proportion of stable α particles and showed reduced glycogen fragility after CS-LYC treatment, linking the gut microbiota to glycogen integrity. - Fecal microbiota transplantation experiments were used to confirm that the observed metabolic and glycogen changes were mediated by gut microbiota. - The abstract does not report specific CS-LYC dosing regimens, treatment duration, animal numbers, or statistical outcomes; full-text methods and limitations must be consulted for those details.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42907031/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42907031%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42907031/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42907031/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42907031/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42907031/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42907031/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42907031/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42907031%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42907031%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42907031/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42907031/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42907031/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42907031/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Full text links [![Elsevier Science full text link](https://cdn.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--linkinghub.elsevier.com-ihub-images-PubMedLink.gif) Elsevier Science ](https://linkinghub.elsevier.com/retrieve/pii/S0144-8617\(26\)01022-2 "See full text options at Elsevier Science") [ Full text links ](https://pubmed.ncbi.nlm.nih.gov/42907031/) ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42907031/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42907031/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42907031/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/42907031/#conflict-of-interest) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/42907031/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/42907031/#substances) * [Related information](https://pubmed.ncbi.nlm.nih.gov/42907031/#related-links) * [ LinkOut - more resources ](https://pubmed.ncbi.nlm.nih.gov/42907031/#linkout) Title & authors Abstract Conflict of interest statement MeSH terms Substances Related information LinkOut - more resources Carbohydr Polym Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Carbohydr+Polym%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Carbohydr+Polym%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907031/) . 2026 Nov 15:392:125905. doi: 10.1016/j.carbpol.2026.125905. Epub 2026 Oct 1. # A V-type starch-lycopene complex with enhanced cis-lycopene content alleviates hyperglycemia and glycogen fragility in type 2 diabetic db/db mice via gut microbiota [Zhengming Zhou](https://pubmed.ncbi.nlm.nih.gov/?term=Zhou+Z&cauthor_id=42907031)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42907031/#full-view-affiliation-1 "Food & Nutritional Sciences Programme, School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong."), [Qile Zhang](https://pubmed.ncbi.nlm.nih.gov/?term=Zhang+Q&cauthor_id=42907031)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42907031/#full-view-affiliation-1 "Food & Nutritional Sciences Programme, School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong."), [Lingyun Zhong](https://pubmed.ncbi.nlm.nih.gov/?term=Zhong+L&cauthor_id=42907031)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42907031/#full-view-affiliation-2 "Department of Nutrition and Food Hygiene, School of Public Health, Southern Medical University, Baiyun District, Guangzhou, Guangdong, 510515, China."), [Xinyi Deng](https://pubmed.ncbi.nlm.nih.gov/?term=Deng+X&cauthor_id=42907031)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42907031/#full-view-affiliation-1 "Food & Nutritional Sciences Programme, School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong."), [Yue Ma](https://pubmed.ncbi.nlm.nih.gov/?term=Ma+Y&cauthor_id=42907031)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42907031/#full-view-affiliation-1 "Food & Nutritional Sciences Programme, School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong."), [Wang Hin Ng](https://pubmed.ncbi.nlm.nih.gov/?term=Ng+WH&cauthor_id=42907031)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42907031/#full-view-affiliation-1 "Food & Nutritional Sciences Programme, School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong."), [Man Siu Lun Renaldi Rahman](https://pubmed.ncbi.nlm.nih.gov/?term=Rahman+MSLR&cauthor_id=42907031)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42907031/#full-view-affiliation-1 "Food & Nutritional Sciences Programme, School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong."), [Jian Zhu](https://pubmed.ncbi.nlm.nih.gov/?term=Zhu+J&cauthor_id=42907031)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42907031/#full-view-affiliation-3 "Department of Food Science and Technology, Faculty of Science, National University of Singapore, Science Drive 4, 117543, Singapore."), [Cheng Li](https://pubmed.ncbi.nlm.nih.gov/?term=Li+C&cauthor_id=42907031)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42907031/#full-view-affiliation-4 "Food & Nutritional Sciences Programme, School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong; State Key Laboratory of Agrobiotechnology, The Chinese University of Hong Kong, Shatin, Hong Kong. Electronic address: cheng.li@cuhk.edu.hk.") Affiliations Expand ### Affiliations * 1 Food & Nutritional Sciences Programme, School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong. * 2 Department of Nutrition and Food Hygiene, School of Public Health, Southern Medical University, Baiyun District, Guangzhou, Guangdong, 510515, China. * 3 Department of Food Science and Technology, Faculty of Science, National University of Singapore, Science Drive 4, 117543, Singapore. * 4 Food & Nutritional Sciences Programme, School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong; State Key Laboratory of Agrobiotechnology, The Chinese University of Hong Kong, Shatin, Hong Kong. Electronic address: cheng.li@cuhk.edu.hk. * PMID: **42907031** * DOI: [ 10.1016/j.carbpol.2026.125905 ](https://doi.org/10.1016/j.carbpol.2026.125905) Item in Clipboard # A V-type starch-lycopene complex with enhanced cis-lycopene content alleviates hyperglycemia and glycogen fragility in type 2 diabetic db/db mice via gut microbiota Zhengming Zhou et al. Carbohydr Polym. 2026. Show details Display options Display options Format Abstract PubMed PMID Carbohydr Polym Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Carbohydr+Polym%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Carbohydr+Polym%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907031/) . 2026 Nov 15:392:125905. doi: 10.1016/j.carbpol.2026.125905. Epub 2026 Oct 1. ### Authors [Zhengming Zhou](https://pubmed.ncbi.nlm.nih.gov/?term=Zhou+Z&cauthor_id=42907031)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42907031/#short-view-affiliation-1 "Food & Nutritional Sciences Programme, School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong."), [Qile Zhang](https://pubmed.ncbi.nlm.nih.gov/?term=Zhang+Q&cauthor_id=42907031)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42907031/#short-view-affiliation-1 "Food & Nutritional Sciences Programme, School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong."), [Lingyun Zhong](https://pubmed.ncbi.nlm.nih.gov/?term=Zhong+L&cauthor_id=42907031)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42907031/#short-view-affiliation-2 "Department of Nutrition and Food Hygiene, School of Public Health, Southern Medical University, Baiyun District, Guangzhou, Guangdong, 510515, China."), [Xinyi Deng](https://pubmed.ncbi.nlm.nih.gov/?term=Deng+X&cauthor_id=42907031)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42907031/#short-view-affiliation-1 "Food & Nutritional Sciences Programme, School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong."), [Yue Ma](https://pubmed.ncbi.nlm.nih.gov/?term=Ma+Y&cauthor_id=42907031)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42907031/#short-view-affiliation-1 "Food & Nutritional Sciences Programme, School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong."), [Wang Hin Ng](https://pubmed.ncbi.nlm.nih.gov/?term=Ng+WH&cauthor_id=42907031)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42907031/#short-view-affiliation-1 "Food & Nutritional Sciences Programme, School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong."), [Man Siu Lun Renaldi Rahman](https://pubmed.ncbi.nlm.nih.gov/?term=Rahman+MSLR&cauthor_id=42907031)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42907031/#short-view-affiliation-1 "Food & Nutritional Sciences Programme, School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong."), [Jian Zhu](https://pubmed.ncbi.nlm.nih.gov/?term=Zhu+J&cauthor_id=42907031)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42907031/#short-view-affiliation-3 "Department of Food Science and Technology, Faculty of Science, National University of Singapore, Science Drive 4, 117543, Singapore."), [Cheng Li](https://pubmed.ncbi.nlm.nih.gov/?term=Li+C&cauthor_id=42907031)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42907031/#short-view-affiliation-4 "Food & Nutritional Sciences Programme, School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong; State Key Laboratory of Agrobiotechnology, The Chinese University of Hong Kong, Shatin, Hong Kong. Electronic address: cheng.li@cuhk.edu.hk.") ### Affiliations * 1 Food & Nutritional Sciences Programme, School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong. * 2 Department of Nutrition and Food Hygiene, School of Public Health, Southern Medical University, Baiyun District, Guangzhou, Guangdong, 510515, China. * 3 Department of Food Science and Technology, Faculty of Science, National University of Singapore, Science Drive 4, 117543, Singapore. * 4 Food & Nutritional Sciences Programme, School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong; State Key Laboratory of Agrobiotechnology, The Chinese University of Hong Kong, Shatin, Hong Kong. Electronic address: cheng.li@cuhk.edu.hk. * PMID: **42907031** * DOI: [ 10.1016/j.carbpol.2026.125905 ](https://doi.org/10.1016/j.carbpol.2026.125905) Item in Clipboard Full text links Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract Type 2 diabetes mellitus (T2DM) is a major global health challenge. Resistant starch type 5 (RS5), formed by complexing starch with guest components into V-type crystalline structures, represents a promising approach for glycemia control. Native lycopene has anti-diabetic potential but limited bioactivity. Here we developed a V-type corn starch-lycopene RS5 complex (CS-LYC) and evaluated its effects in T2DM db/db mice, focusing on glycemic control and gut microbiota-liver glycogen connection. CS-LYC contained 26.07% resistant starch and 11.8 mg/g lycopene, with complexation promoting isomerization to the more bioactive (13Z)-isomer and increasing lycopene accumulation in both plasma and liver in vivo. In db/db mice, CS-LYC improved insulin sensitivity and glucose homeostasis by remodeling gut microbiota (enriching Akkermansia and Alistipes) and increasing metabolites (short-chain fatty acids and indole derivatives), subsequently maintaining intestinal barrier function and stimulating GLP-1 secretion. Through the gut-liver axis, this GLP-1 activated the hepatic PI3K/AKT pathway and increased the proportion of stable glycogen α particles, thereby reducing glycogen fragility, with fecal microbiota transplantation further confirming that these effects were mediated by gut microbiota. Collectively, CS-LYC alleviates T2DM via the gut-liver GLP-1/PI3K-AKT axis, offering a new dietary strategy for diabetes management. **Keywords:** Glycogen fragility; Gut microbiota; Lycopene; PI3K-AKT pathway; Resistant starch; Type 2 diabetes mellitus. Copyright © 2026 Elsevier Ltd. All rights reserved. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. ## MeSH terms * Animals Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Animals%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Animals) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907031/) * Blood Glucose Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Blood+Glucose%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Blood+Glucose) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907031/) * Diabetes Mellitus, Type 2* / drug therapy Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Diabetes+Mellitus%2C+Type+2%2Fdrug+therapy%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Diabetes+Mellitus%2C+Type+2) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907031/) * Diabetes Mellitus, Type 2* / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Diabetes+Mellitus%2C+Type+2%2Fmetabolism%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Diabetes+Mellitus%2C+Type+2) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907031/) * Diabetes Mellitus, Type 2* / microbiology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Diabetes+Mellitus%2C+Type+2%2Fmicrobiology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Diabetes+Mellitus%2C+Type+2) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907031/) * Gastrointestinal Microbiome* / drug effects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Gastrointestinal+Microbiome%2Fdrug+effects%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Gastrointestinal+Microbiome) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907031/) * Glycogen* / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Glycogen%2Fmetabolism%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Glycogen) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907031/) * Hyperglycemia* / drug therapy Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Hyperglycemia%2Fdrug+therapy%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Hyperglycemia) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907031/) * Hyperglycemia* / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Hyperglycemia%2Fmetabolism%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Hyperglycemia) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907031/) * Hypoglycemic Agents* / ch
## Related Clinical Research

- [mPEG-PSA Nanocarriers Enable Glucose‑Responsive Insulin Aspart Release in Diabetic Mice](https://medichelpline.com/clinical-feed/pubmed-42927605.md) (DOI: 10.1021/acsabm.6c01204)
- [Macrophage HDAC3 and GDF3 Drive Adipose Inflammation and Metabolic Dysfunction](https://medichelpline.com/clinical-feed/pubmed-42731468.md) (DOI: 10.1016/j.intimp.2026.117385)
- [Metformin reduces metabolic and oxidative changes in a high-sucrose Drosophila model](https://medichelpline.com/clinical-feed/plos-one-13-metformin-modulates-survival-oxidative-stress-and-gene-expression-in-a-high.md)
- [Amylyx Presents Avexitide Results; MiniMed Launches Tubeless Insulin Pump](https://medichelpline.com/clinical-feed/endocrine-news-0-pharma-friday-november-21-2026.md)
- [U.S. POINTER: Structured lifestyle program slows brain aging and cardiometabolic risk over 24 mont](https://medichelpline.com/clinical-feed/medical-news-today-0-combining-physical-mental-and-social-habits-slows-brain-aging-in-2-year-trial.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.